Radioiodine: 80 years and counting; the past, present, and future

In this issue of Endocrine-Related Cancer we celebrate the 80th anniversary of the first reported therapeutic use of radioiodine with a special issue dedicated to the history, current uses, and future research for this cornerstone of thyroid cancer therapy. Edited by Professor Christopher McCabe, one of our outstanding Associate Editors and an expert in thyroid cancer biology, a panel of expert authors provide six comprehensive and up-to-date reviews covering important topics for endocrine oncology researchers and clinicians.